12:00 AM
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

APL-130277: Phase I started

Cynapsus disclosed in its 3Q12 earnings that it began the placebo-controlled, crossover Phase I CTH-103 trial to compare multiple doses...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >